CCK‐JMV‐180 acts as an antagonist of the CCK<sub>A</sub> receptor in the human IMR‐32 neuroblastoma cell line

P. Schaeffer, V. Prabonnaud, M. Roux, D. Gully, J.M. Herbert

Open source

DOI
10.1016/0014-5793(94)01114-1
Published
1994-11-07
Container
FEBS Letters
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/0014-5793-94-01114-1,
  title = {CCK‐JMV‐180 acts as an antagonist of the CCK<sub>A</sub> receptor in the human IMR‐32 neuroblastoma cell line},
  author = {P. Schaeffer and V. Prabonnaud and M. Roux and D. Gully and J.M. Herbert},
  year = {1994},
  journal = {FEBS Letters},
  doi = {10.1016/0014-5793(94)01114-1},
  url = {https://doi.org/10.1016/0014-5793(94)01114-1}
}

RIS

TY  - JOUR
TI  - CCK‐JMV‐180 acts as an antagonist of the CCK<sub>A</sub> receptor in the human IMR‐32 neuroblastoma cell line
AU  - P. Schaeffer
AU  - V. Prabonnaud
AU  - M. Roux
AU  - D. Gully
AU  - J.M. Herbert
PY  - 1994
JO  - FEBS Letters
DO  - 10.1016/0014-5793(94)01114-1
UR  - https://doi.org/10.1016/0014-5793(94)01114-1
ER  - 

APA

Schaeffer, P., Prabonnaud, V., Roux, M., Gully, D., & Herbert, J. (1994). CCK‐JMV‐180 acts as an antagonist of the CCK<sub>A</sub> receptor in the human IMR‐32 neuroblastoma cell line. FEBS Letters. https://doi.org/10.1016/0014-5793(94)01114-1

Source records